Rubella IgG ELISA Kit


Human rubella IgG ELISA kit is a method intended for analysing in-vitro quantitative levels of human IgG antibodies against rubellavirus (rubella-IgG) virus in samples of serum and plasma. This assay has a minimum analytical sensitivity limit of 0.38 IU/ml.


Rubella virus belongs to the family Togaviridae, it is between 40-80 nm, single-stranded, positive-sense, spherical RNA virus which contains hemagglutinin surface projections. It is made up of three major structural polypeptides and is the only serotype which has been identified. Rubella (also known as German measles) is a common mild disease that can be characterised by a rash, it can be transmitted through direct or droplet contact with respiratory secretions. When rubella virus infects susceptible women during the early of pregnancy, it can be transmitted to the fetus which could lead to possible birth defects. In general, it is found to affects children and adolescents throughout the worldwide, it can also affect young adults. Laboratory methods which can be used to detecting rubella include ELISA assays, hemagglutination inhibition test (HIT) and hemolysis-in-gel test. The IgG test is helpful in determining immunity, whereas virus-specific IgM antibodies detection is crucial in measuring a fresh infection.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Rubella Antigen Coated Microtiter Strips
  • Calibrators (A-E): 0, 10, 50, 200, 500 IU/mL.
  • Enzyme Conjugate.
  • TMB Substrate.
  • Stop Solution.
  • Sample Diluent.
  • Washing Buffer (10x)
  • Plastic Foils
  • Plastic Bag (x2).


The minimum detection sensitivity level of IgG antibodies to rubellavirus (rubella IgG) using current human rubella-IgG ELISA kit was 0.38 IU/ml. The dynamic range for this assay is 0 – 500 IU/ml.


– Rubellavirus ELISA: IgG
– Intra-Assay-Precision: 4.3 – 7.2 %
– Inter-Assay-Precision: 2.6 – 17.0 %
– Inter-Lot-Precision: 5.3 – 23.2 %
– Recovery: 102 – 118 %
– Linearity: 75 – 110 %
– Cross-Reactivity: No cross-reactivity to herpes 1, cytomegaly, toxoplasma, dsDNA, measles, mumps, varicella and EBV-VCA.
– Interferences: No interferences to bilirubin up to 0.3 mg/mL, hemoglobin up to 8.0 g/mL and triglycerides up to 5.0 mg/mL.
– Clinical Specificity: 100 %
– Clinical Sensitivity: 100 %


  1. Investigation into low-level anti rubellavirus IgG results reported by commercial immunoassays. Clin Vaccine Immunol. (2013) 20 (2): 255-61. Dimech W., et al.
  2. Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies. Clin Microbiol Rev. (2016) 29 (1): 163-74. Review. Dimech W., et al.
  3. Prevalence of rubella-specific IgG antibodies in unimmunized young female population. J Family Med Prim Care. (2016) 5 (3): 658-662. Thayyil J., et al.
  4. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol. (1997) 8 (2): 105-11. Böttiger B. and Jensen I.P.
  5. Placental transfer of rubella-specific IgG in fullterm and preterm newborns. Int J Gynaecol Obstet. (2003) 81 (2): 157-62. Doroudchi M., et al.


  • Full Name: Rubella IgG ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 0.38 IU/ml



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford